rs909982
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_020737.3(LRFN2):c.-19+67617T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.573 in 152,024 control chromosomes in the GnomAD database, including 25,332 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.57 ( 25332 hom., cov: 32)
Consequence
LRFN2
NM_020737.3 intron
NM_020737.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.124
Publications
3 publications found
Genes affected
LRFN2 (HGNC:21226): (leucine rich repeat and fibronectin type III domain containing 2) Predicted to be involved in modulation of chemical synaptic transmission and regulation of postsynapse organization. Predicted to be located in plasma membrane. Predicted to be active in Schaffer collateral - CA1 synapse and cell surface. Predicted to be integral component of postsynaptic density membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.643 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LRFN2 | NM_020737.3 | c.-19+67617T>C | intron_variant | Intron 1 of 2 | ENST00000338305.7 | NP_065788.1 | ||
| LOC105379699 | NR_182433.1 | n.135-1811T>C | intron_variant | Intron 1 of 2 | ||||
| LOC105379699 | NR_182434.1 | n.135-1811T>C | intron_variant | Intron 1 of 2 | ||||
| LOC105379699 | NR_182435.1 | n.135-1811T>C | intron_variant | Intron 1 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.573 AC: 87058AN: 151902Hom.: 25322 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
87058
AN:
151902
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.573 AC: 87106AN: 152024Hom.: 25332 Cov.: 32 AF XY: 0.574 AC XY: 42632AN XY: 74284 show subpopulations
GnomAD4 genome
AF:
AC:
87106
AN:
152024
Hom.:
Cov.:
32
AF XY:
AC XY:
42632
AN XY:
74284
show subpopulations
African (AFR)
AF:
AC:
24118
AN:
41444
American (AMR)
AF:
AC:
7149
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
2402
AN:
3472
East Asian (EAS)
AF:
AC:
2189
AN:
5166
South Asian (SAS)
AF:
AC:
3190
AN:
4816
European-Finnish (FIN)
AF:
AC:
6522
AN:
10538
Middle Eastern (MID)
AF:
AC:
199
AN:
294
European-Non Finnish (NFE)
AF:
AC:
39703
AN:
67982
Other (OTH)
AF:
AC:
1276
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1888
3777
5665
7554
9442
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
754
1508
2262
3016
3770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1909
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.